Puberty blocker prescription pause

The story so far

Health Minister Simeon Brown announced that Cabinet had agreed to stop doctors prescribing puberty blockers to new young patients with gender dysphoria.^{19 Nov 2025} The government said the move was precautionary because the evidence on risks and benefits is uncertain, and the rules would stay in place until a major clinical trial in the United Kingdom is completed.^{19 Nov 2025} Medical professionals criticised the pause the next day, calling it politically motivated and discriminatory, and noted that it does not apply to the same medications used for other medical conditions.^{20 Nov 2025} In December the High Court issued an urgent injunction temporarily pausing the ban, which had been due to take effect that week, pending a judicial review.^{17 Dec 2025}

What's next

The ban was tied to the completion of a major UK clinical trial, which the stories do not say has been completed.^{19 Nov 2025}

Key moments

1. 19 Nov 2025Cabinet agrees to stop new puberty blocker prescriptions for gender dysphoria patients.
2. 20 Nov 2025Doctors call the pause politically motivated and discriminatory.
3. 17 Dec 2025High Court issues urgent injunction, delaying enforcement of the ban pending judicial review.

Written from the stories below; each sentence links to its sources.